PROS1 and posterior cortical atrophy: Currently, the World Health Organization (WHO) grade grouping based on architectural features and the measurement of serum prostate‐specific antigen (PSA), along with other clinical parameters such as T‐stage, is primarily used to predict the prognosis and progression of PCa.